Metastatic renal cell carcinoma regains sensitivity to tyrosine kinase inhibitor after nivolumab treatment: A case report

Oncology Letters ◽

10.3892/ol.2019.10027 ◽

2019 ◽

Author(s):

Takeshi Azuma ◽

Tohru Sugihara ◽

Sachi Honda ◽

Uran Yoshizaki ◽

Fusako Niimi ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Case Report ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Kinase Inhibitor

Download Full-text

When tyrosine kinase inhibitor sunitinib can be discontinued in metastatic renal cell carcinoma to pancreas: a case report

Journal of Medical Case Reports ◽

10.1186/s13256-018-1597-z ◽

2018 ◽

Vol 12 (1) ◽

Author(s):

Yassir Sbitti ◽

Adil Debbagh ◽

Khaoula Slimani ◽

Mohamed Mahi ◽

Hassan Errihani ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Case Report ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Kinase Inhibitor

Download Full-text

A Case of Metastatic Renal Cell Carcinoma to the Maxillary Sinus Treated with Tyrosine Kinase Inhibitor

Korean Journal of Otorhinolaryngology - Head and Neck Surgery ◽

10.3342/kjorl-hns.2012.55.11.717 ◽

2012 ◽

Vol 55 (11) ◽

pp. 717 ◽

Author(s):

Young Hyo Kim ◽

Jae Eun Kim ◽

Sungmin Park ◽

Tae Young Jang

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Maxillary Sinus ◽

Metastatic Renal Cell Carcinoma ◽

Kinase Inhibitor

Download Full-text

Faculty Opinions recommendation of Does timing of cytoreductive nephrectomy impact patient survival with metastatic renal cell carcinoma in the tyrosine kinase inhibitor era? A multi-institutional study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717979900.793471988 ◽

2013 ◽

Author(s):

Hendrik van Poppel ◽

Yuri Tolkach

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Kinase Inhibitor ◽

Patient Survival ◽

Cytoreductive Nephrectomy

Download Full-text

Long-term outcomes of tyrosine kinase inhibitor discontinuation in patients with metastatic renal cell carcinoma

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-015-2942-1 ◽

2015 ◽

Vol 77 (2) ◽

pp. 339-347 ◽

Author(s):

Dong-Hoe Koo ◽

Inkeun Park ◽

Jin-Hee Ahn ◽

Dae-Ho Lee ◽

Dalsan You ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Kinase Inhibitor ◽

Long Term Outcomes ◽

Tyrosine Kinase Inhibitor Discontinuation

Download Full-text

Influence of Prior Tyrosine Kinase Inhibitor on Survival for Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab or Cabozantinib: Data from a Literature-based Meta-analysis

European Urology ◽

10.1016/j.eururo.2017.07.019 ◽

2017 ◽

Vol 72 (6) ◽

pp. 1027-1028 ◽

Author(s):

Giandomenico Roviello ◽

Daniele Generali

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Kinase Inhibitor ◽

Download Full-text

The Adiponectin-AdipoR1 Axis Mediates Tumor Progression and Tyrosine Kinase Inhibitor Resistance in Metastatic Renal Cell Carcinoma

Neoplasia ◽

10.1016/j.neo.2019.07.004 ◽

2019 ◽

Vol 21 (9) ◽

pp. 921-931 ◽

Author(s):

Guangxi Sun ◽

Xingming Zhang ◽

Zhenhua Liu ◽

Sha Zhu ◽

Pengfei Shen ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Tumor Progression ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Kinase Inhibitor ◽

Inhibitor Resistance

Download Full-text

7108 Phase II study of IMC-1121B in patients with metastatic renal cell carcinoma (mRCC) following failure of VEGFR-2 tyrosine kinase inhibitor (TKI) therapy: interim results (IMCL CP12–0605/NCT00515697)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(09)71441-7 ◽

2009 ◽

Vol 7 (2) ◽

pp. 425 ◽

Author(s):

J.A. Garcia ◽

G. Hudes ◽

T.K. Choueiri ◽

W.M. Stadler ◽

L. Wood ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Kinase Inhibitor ◽

Download Full-text

Effect of the timing of best tumor shrinkage on survival of patients with metastatic renal cell carcinoma who received first-line tyrosine kinase inhibitor therapy

International Journal of Clinical Oncology ◽

10.1007/s10147-016-1032-7 ◽

2016 ◽

Vol 22 (1) ◽

pp. 126-135 ◽

Author(s):

Hiroki Ishihara ◽

Takafumi Yagisawa ◽

Tsunenori Kondo ◽

Kenji Omae ◽

Toshio Takagi ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Kinase Inhibitor ◽

Tumor Shrinkage ◽

Tyrosine Kinase Inhibitor Therapy

Download Full-text

Metastatic renal cell carcinoma: how to make the best sequencing decision after withdrawal for intolerance to a tyrosine kinase inhibitor

Future Oncology ◽

10.2217/fon.13.58 ◽

2013 ◽

Vol 9 (6) ◽

pp. 831-843 ◽

Author(s):

Roberto Sabbatini ◽

Cinizia Ortega ◽

Giuseppe Procopio ◽

Cristina Masini ◽

Enzo Galligioni ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Kinase Inhibitor

Download Full-text

MP66-02 SURVIVAL ANALYSIS OF PATIENTS WITH METASTATIC RENAL CELL CARCINOMA UNDERGOING CYTOREDUCTIVE NEPHRECTOMY WITH OR WITHOUT A NEOADJUVANT TYROSINE KINASE INHIBITOR

The Journal of Urology ◽

10.1016/j.juro.2018.02.1874 ◽

2018 ◽

Vol 199 (4S) ◽

Author(s):

Jing Zhi Lo ◽

Peter Sunaryo ◽

David Paulucci ◽

Ketan Badani

Keyword(s):

Renal Cell Carcinoma ◽

Survival Analysis ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Kinase Inhibitor ◽

Cytoreductive Nephrectomy

Download Full-text